SCHEMBL9457333

SCHEMBL9457333

CCCCCC[C@H](C)[C@H](C[C@@H](CCCCCCCCCCC(=O)O)OC1CCCCO1)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.33
FFAR1 O14842 1/20 0.33
PTGER2 P43116 4/20 0.32
TBXA2R P21731 1/20 0.32
PTGFR P43088 1/20 0.32
ALDH1A1 P00352 2/20 0.32
PTGER4 P35408 5/20 0.31
PTGER3 P43115 3/20 0.31
TSHR P16473 2/20 0.31
TBXAS1 P24557 1/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
ABCC3 O15438 1/20 0.31
ABCC4 O15439 1/20 0.31
RARB P10826 1/20 0.31
RARG P13631 1/20 0.31
DRD1 P21728 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9457010 0.85 MEN1 (0.32) MEN1KMT2A
SCHEMBL3707695 0.82 FFAR4 (0.46) FFAR4FFAR1ALDH1A1TSHRMEN1
SCHEMBL10539802 0.79 PTGFR (0.46) PTGER2TBXA2RPTGFRALDH1A1PTGER4
SCHEMBL9825750 0.77 TLR2 (0.33)
SCHEMBL2030947 0.76 ALOX5 (0.32)
SCHEMBL2030944 0.76 ALOX5 (0.32)
SCHEMBL2030946 0.76 ALOX5 (0.32)
SCHEMBL10537899 0.76 PTGFR (0.42) PTGER2TBXA2RPTGFRALDH1A1PTGER3
SCHEMBL10538424 0.76 PTGFR (0.42) PTGER2TBXA2RPTGFRALDH1A1PTGER3
SCHEMBL10603626 0.75 SPHK1 (0.32) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246960-A Used to treat obesity, hyperlipaemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1993-09-21 US disclosed